Pardes Biosciences (PRDS) Income Statement (2021 - 2023)
Income Statement report data from Dec 31, 2021 to Mar 31, 2023 for Pardes Biosciences (PRDS).
Reported currency: USD
| Mar 31, 2023 | Feb 14, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2022 | Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||
Research And Development | 13M (+87.30%) | 6.93M (-64.33%) | 19M (-4.47%) | 20M (+54.09%) | 13M (0.00%) | 13M (+27.41%) | 10M |
Selling General And Administrative | 6.83M (+20.04%) | 5.69M (-15.45%) | 6.73M (-11.33%) | 7.59M (-7.78%) | 8.23M (0.00%) | 8.23M (+108.35%) | 3.95M |
Operating Expenses | 20M (+56.97%) | 13M (-51.76%) | 26M (-6.37%) | 28M (+30.38%) | 21M (0.00%) | 21M (+49.76%) | 14M |
Operating Income | |||||||
Operating Income | -19.81M (+57.10%) | -12.61M (-51.80%) | -26.16M (-6.34%) | -27.93M (+30.39%) | -21.42M (0.00%) | -21.42M (+49.69%) | -14.31M |
EBITDA | -19.81M (+57.10%) | -12.61M (-51.80%) | -26.16M (-6.34%) | -27.93M (+30.39%) | -21.42M (0.00%) | -21.42M (+49.69%) | -14.31M |
Other Income / Expenses | |||||||
Interest Income | - | - | - | - | - | - | -40.00K |
Interest Expense | 2.00M (+8.70%) | 1.84M | - | 300K | -10.00K (0.00%) | -10.00K | - |
Net Interest Income | -2.00M (+8.70%) | -1.84M | - | -300.00K | 20K (0.00%) | 20K | -40.00K |
Net Income | |||||||
Income Before Tax | -17.80M (+65.27%) | -10.77M (-55.53%) | -24.22M (-12.37%) | -27.64M (+28.92%) | -21.44M (0.00%) | -21.44M (+49.41%) | -14.35M |
Net Income From Continuing Operations | -17.80M (+65.27%) | -10.77M (-55.53%) | -24.22M (-12.37%) | -27.64M (+28.92%) | -21.44M (0.00%) | -21.44M (+49.41%) | -14.35M |
Net Income | -17.80M (+65.27%) | -10.77M (-55.53%) | -24.22M (-12.37%) | -27.64M (+28.92%) | -21.44M (0.00%) | -21.44M (+49.41%) | -14.35M |